APA
Hao H., Wang H., Liu C., Kovats S., Velazquez R., Lu H., Pant B., Shirley M., Meyer M. J., Pu M., Lim J., Fleming M., Alexander L., Farsidjani A., LaMarche M. J., Moody S., Silver S. J., Caponigro G., Stuart D. D., Abrams T. J., Hammerman P. S., Williams J., Engelman J. A., Goldoni S. & Mohseni M. (20200707). Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. : Molecular cancer therapeutics.
Chicago
Hao Huai-Xiang, Wang Hongyun, Liu Chen, Kovats Steven, Velazquez Roberto, Lu Hengyu, Pant Bhavesh, Shirley Matthew, Meyer Matthew J, Pu Minying, Lim Joanne, Fleming Michael, Alexander LeighAnn, Farsidjani Ali, LaMarche Matthew J, Moody Susan, Silver Serena J, Caponigro Giordano, Stuart Darrin D, Abrams Tinya J, Hammerman Peter S, Williams Juliet, Engelman Jeffrey A, Goldoni Silvia and Mohseni Morvarid. 20200707. Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. : Molecular cancer therapeutics.
Harvard
Hao H., Wang H., Liu C., Kovats S., Velazquez R., Lu H., Pant B., Shirley M., Meyer M. J., Pu M., Lim J., Fleming M., Alexander L., Farsidjani A., LaMarche M. J., Moody S., Silver S. J., Caponigro G., Stuart D. D., Abrams T. J., Hammerman P. S., Williams J., Engelman J. A., Goldoni S. and Mohseni M. (20200707). Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. : Molecular cancer therapeutics.
MLA
Hao Huai-Xiang, Wang Hongyun, Liu Chen, Kovats Steven, Velazquez Roberto, Lu Hengyu, Pant Bhavesh, Shirley Matthew, Meyer Matthew J, Pu Minying, Lim Joanne, Fleming Michael, Alexander LeighAnn, Farsidjani Ali, LaMarche Matthew J, Moody Susan, Silver Serena J, Caponigro Giordano, Stuart Darrin D, Abrams Tinya J, Hammerman Peter S, Williams Juliet, Engelman Jeffrey A, Goldoni Silvia and Mohseni Morvarid. Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. : Molecular cancer therapeutics. 20200707.